1例AECOPD伴良性前列腺增生患者使用支气管扩张药致急性尿潴留的药学监护

发布时间：2018-03-06 01:31

本文选题：临床药师　切入点：药学监护　出处：《中国药房》2017年20期 　论文类型：期刊论文

【摘要】：目的:探讨临床药师在慢性阻塞性肺疾病急性加重期(AECOPD)合并良性前列腺增生(BPH)患者药物治疗中的作用。方法:临床药师参与1例AECOPD合并BPH患者的药物治疗过程,参考临床指南和相关文献,结合患者疾病史、支气管扩张药作用特点及急性尿潴留症状,建议停用吸入用异丙托溴铵溶液,加用非那雄胺胶囊5 mg,po,qd缩小前列腺体积、改善梗阻+盐酸特拉唑嗪片2 mg,po,qd松弛尿道平滑肌,并密切监测有无相关不良反应发生;建议患者出院后选用沙美特罗替卡松粉吸入剂,并给予用药指导。结果:医师部分采纳临床药师建议。患者病情稳定,未再出现排尿困难,准予带药出院。结论:支气管扩张药的合理应用直接关系到AECOPD患者临床症状的缓解及其预后。临床药师通过结合患者疾病史、药物作用特点和临床症状,指出了使用抗胆碱药可能存在的风险,协助医师制订和调整了治疗方案,保证了患者用药的安全性和有效性。
[Abstract]:Objective: to investigate the role of clinical pharmacists in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and benign prostatic hyperplasia (BPH). With reference to clinical guidelines and related literature, combined with patient history of disease, bronchiectasis characteristics and symptoms of acute urinary retention, it was suggested that inhaled ipratropium bromide solution should be stopped and fenasteride capsule 5 mg / po QD should be added to reduce the volume of prostate. To improve the obstruction of terazosin hydrochloride tablets 2 mg / kg poqd relaxation urethral smooth muscle and closely monitor the occurrence of related adverse reactions. Results: the physician partially accepted the advice of the clinical pharmacist. The patient was in a stable condition and had no difficulty in urinating. Conclusion: the reasonable use of bronchiectasis is directly related to the relief of clinical symptoms and prognosis of AECOPD patients. The possible risks of using anticholine drugs were pointed out, and the safety and effectiveness of anticholine drugs were ensured by assisting doctors to formulate and adjust the treatment plan.
【作者单位】：重庆市垫江县人民医院药剂科;重庆市垫江县人民医院呼吸内科;
【分类号】：R563.9;R697.3

【相似文献】